Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in women (7%) and the sixth in men (5%) in Italy, with a life expectancy of around 5% at 5 years. From 2010, the Italian Association of Medical Oncology (AIOM) developed national guidelines for several cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestris, Nicola, Brunetti, Oronzo, Bittoni, Alessandro, Cataldo, Ivana, Corsi, Domenico, Crippa, Stefano, D’Onofrio, Mirko, Fiore, Michele, Giommoni, Elisa, Milella, Michele, Pezzilli, Raffaele, Vasile, Enrico, Reni, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352458/
https://www.ncbi.nlm.nih.gov/pubmed/32599886
http://dx.doi.org/10.3390/cancers12061681
_version_ 1783557642817372160
author Silvestris, Nicola
Brunetti, Oronzo
Bittoni, Alessandro
Cataldo, Ivana
Corsi, Domenico
Crippa, Stefano
D’Onofrio, Mirko
Fiore, Michele
Giommoni, Elisa
Milella, Michele
Pezzilli, Raffaele
Vasile, Enrico
Reni, Michele
author_facet Silvestris, Nicola
Brunetti, Oronzo
Bittoni, Alessandro
Cataldo, Ivana
Corsi, Domenico
Crippa, Stefano
D’Onofrio, Mirko
Fiore, Michele
Giommoni, Elisa
Milella, Michele
Pezzilli, Raffaele
Vasile, Enrico
Reni, Michele
author_sort Silvestris, Nicola
collection PubMed
description Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in women (7%) and the sixth in men (5%) in Italy, with a life expectancy of around 5% at 5 years. From 2010, the Italian Association of Medical Oncology (AIOM) developed national guidelines for several cancers. In this report, we report a summary of clinical recommendations of diagnosis, treatment and follow-up of PDAC, which may guide physicians in their current practice. A panel of AIOM experts in upper gastrointestinal cancer malignancies discussed the available scientific evidence supporting the clinical recommendations.
format Online
Article
Text
id pubmed-7352458
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73524582020-07-15 Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM) Silvestris, Nicola Brunetti, Oronzo Bittoni, Alessandro Cataldo, Ivana Corsi, Domenico Crippa, Stefano D’Onofrio, Mirko Fiore, Michele Giommoni, Elisa Milella, Michele Pezzilli, Raffaele Vasile, Enrico Reni, Michele Cancers (Basel) Review Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in women (7%) and the sixth in men (5%) in Italy, with a life expectancy of around 5% at 5 years. From 2010, the Italian Association of Medical Oncology (AIOM) developed national guidelines for several cancers. In this report, we report a summary of clinical recommendations of diagnosis, treatment and follow-up of PDAC, which may guide physicians in their current practice. A panel of AIOM experts in upper gastrointestinal cancer malignancies discussed the available scientific evidence supporting the clinical recommendations. MDPI 2020-06-24 /pmc/articles/PMC7352458/ /pubmed/32599886 http://dx.doi.org/10.3390/cancers12061681 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Silvestris, Nicola
Brunetti, Oronzo
Bittoni, Alessandro
Cataldo, Ivana
Corsi, Domenico
Crippa, Stefano
D’Onofrio, Mirko
Fiore, Michele
Giommoni, Elisa
Milella, Michele
Pezzilli, Raffaele
Vasile, Enrico
Reni, Michele
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
title Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
title_full Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
title_fullStr Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
title_full_unstemmed Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
title_short Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM)
title_sort clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: evidence evaluation and recommendations by the italian association of medical oncology (aiom)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352458/
https://www.ncbi.nlm.nih.gov/pubmed/32599886
http://dx.doi.org/10.3390/cancers12061681
work_keys_str_mv AT silvestrisnicola clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT brunettioronzo clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT bittonialessandro clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT cataldoivana clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT corsidomenico clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT crippastefano clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT donofriomirko clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT fioremichele clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT giommonielisa clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT milellamichele clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT pezzilliraffaele clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT vasileenrico clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom
AT renimichele clinicalpracticeguidelinesfordiagnosistreatmentandfollowupofexocrinepancreaticductaladenocarcinomaevidenceevaluationandrecommendationsbytheitalianassociationofmedicaloncologyaiom

Ejemplares similares